Cancer
Conditions
Keywords
COVID-19, POST TRAUMATIC STRESS, CANCER, ANXIETY, REORGANISATION OF CARE
Brief summary
The COVID-19 pandemic is a traumatic event which could lead to a greater risk of developing post-traumatic stress disorder, especially in cancer patients who feel more at risk of contracting the virus, and fear developing serious symptoms. The study's primary objective is to measure the presence of a potential post-traumatic stress disorder in cancer patients, and to assess the associated factors. The secondary objectives are to measure patients' anxiety, as well as their perception of both the management of their cancer care, and their fear of a cancer recurrence. It is a prospective, multi-centric study using self-assessing survey offered to cancer patients currently under ongoing care or treatment. The surveys will be sent by post at the beginning of the study, and again 6 months later. Expecting a participation rate of 40%, 4000 patients will be contacted, over a period of 3 months, in order to receive 1600 responses, and 640 responses 6 months later. Researching the factors associated with the appearance of post-traumatic stress could lead to better screening of patient disorders in highly anxiety-provoking crisis situations. As a result, it would lead to an improvement of their care, healthcare organization, and their follow-up in the case of a new epidemic or any other stressful event of this magnitude. Furthermore, promoting the patient's expression capabilities favors their implication in their care, and facilitates the development of health democracy.
Interventions
OTHERSurvey to assess Post traumatic stress and anxiety at inclusion and 6 months later
The first survey will include questions relative to sociodemographic characteristics, existence of psychological troubles; living conditions in the Covid19 pandemic context; IES-R, Stait Trait Anxiety, and the fear of a cancer recurrence scales, satisfaction with cancer care and medical status of patients (diagnosis, ongoing treatment, follow-up of the disease).
Sponsors
Institut Paoli-Calmettes
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Man or woman, age\>18 * Diagnosis of cancer (solid tumor or hematology) * Out patient or patient Under surveillance
Exclusion criteria
* Refusal to participate in the study * Emergency, person deprived of liberty * hospitalized patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of the Impact of Event Scale Revisited scale | at inclusion and 6 months later |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measure of the patient's anxiety | at inclusion and 6 months later | The measure of anxiety, measured by the State-Trait Anxiety Questionnaire |
| proportion of patients perceiving poorer management of their cancer care since the start of the COVID-19 epidemic. | at inclusion and 6 months later | — |
| proportion of patients perceiving the implementation of all necessary measures to reduce the risk of exposure to COVID-19 | at inclusion and 6 months later | — |
| Factors associated with post-traumatic stress disorder | at inclusion and 6 months later | The factors associated with post traumatic stress, measured by the Impact of Event Scale Revisited scale |
| proportion of patients with access to a clinical psychology consultation (at the hospital or on the phone) | at inclusion and 6 months later | — |
| Score on the cancer recurrence scale | at inclusion and 6 months later | — |
| proportion of patients stating that remote consultation is as useful as a face-to-face consultation | at inclusion and 6 months later | — |
Countries
France
Outcome results
None listed